Abstract
The recently published 2 reports of the International Harmonization Project (IHP) in Lymphoma recommended the routine use of 18F-FDG PET for posttherapy assessment of patients with Hodgkin's disease (HD) and diffuse large B-cell lymphoma, the most common and potentially curable form of aggressive
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
